Abstract: Excessive scarring or fibrosis is a common feature of a wide spectrum of diseases characterized by an exaggerated Th2 response. The TLR/IL-1 receptor (IL-1R)-related protein ST2 is expressed in a membrane-bound form selectively by Th2 cells and was shown to be indispensable for some in vivo Th2 responses. ST2 was also found to block TLR signaling. We addressed the impact of the ST2 pathway on fibrogenesis using a mouse model of hepatic injury and fibrosis induced by carbon tetrachloride (CCl 4 ). We showed that cytokine production by intrahepatic lymphocytes from 
INTRODUCTION
The IL-1 receptor (IL-1R)-related gene ST2 encodes a secreted (sST2) and a membrane-bound (ST2L) protein [1] . sST2 was discovered originally in fibroblasts and was later found to be secreted by human and mouse macrophages and by human Th2 cells [1] [2] [3] [4] . It is most important that ST2L appears to be a stable and selective marker expressed by mouse and human Th2 cells (characterized by a discrete cytokine pattern including IL-4, -5, -9, -10, -13, -25, and -31), but not by Th1 cells [4 -6] . ST2L is also expressed by mouse IL-10-secreting Type 1 regulatory T cells, IL-4-producing mastocytes, and human Type 2 cytotoxic and NK2 cell lines [7] [8] [9] [10] . In vitro, ST2L expression by Th2 cells is up-regulated significantly by proinflammatory cytokines IL-6, IL-1, and TNF-␣ and suppressed by a Th1 cytokine IFN-␥ [11, 12] . ST2 appears to participate in two different pathways, a direct, positive regulation of Th2 function, and suppression of Th1 inflammatory response. In the former pathway, crosslinking of ST2L on Th2 cells stimulates production of Type 2 cytokines [11] . The underlying mechanism remained unclear until the recent discovery of IL-33, a ST2L ligand-activating NF-B and MAPK, and driving IL-4, -5, and -13 production by Th2 cells [13] .
In murine respiratory mucosa, positive signaling through ST2L is indispensable for triggering and/or maintenance of Th2 response, and soluble ST2-Fc works as a decoy receptor [14 -18] . Positive regulation of pulmonary Th2 response by ST2L holds true for "Th2-prone" BALB/c and for "Th1-prone" C57Bl/6 mice [5, 14, 16, 18 -20] .
In addition to stimulating the Th2 response directly, sST2 was shown to suppress expression of TLR-1, -2, -4, and -9 by macrophages. sST2 is postulated to signal through an unknown receptor, which is up-regulated upon TLR-4 engagement [21, 22] . As a result, proinflammatory cytokines IL-6, IL-12, IL-1, and TNF-␣ are down-regulated, and mice are protected from endotoxic shock [21, 22] . Moreover, the intracellular Toll-IL-1R domain of ST2L was shown to inhibit signaling through IL-1R and TLR-4 by sequestering their adaptor protein MyD88 and MyD88 adaptor-like protein [22] . Thus, sST2 and ST2L are able to negatively regulate a TLR-supported Th1 response. In accordance with this model, ST2-Fc injected in vivo suppressed Th1-driven, collagen-induced arthritis and down-regulated IL-6, IL-12, IFN-␥, and TNF-␣ [23] .
However, the role of the ST2 pathway in regulation of Th1/Th2 balance is not always clear. Effector Th2 response to Nippostrongylus brasiliensis in the intestinal tract of ST2 knockout (KO) or sST2 transgenic (TG) mice is intact [24] . Similarly, treatment with ST2-Fc or with anti-ST2 mAb fails to abrogate the Th2 response in footpads of Leishmania majorinfected BALB/c mice [25] . Together, these data suggest that the role of the ST2 pathway in immune/inflammatory reactions varies in different tissues. To evaluate this postulate, we studied ST2 regulation of repeated injury, inflammation, and resultant fibrosis in the liver, which unlike lung, has no strong predisposition to Th2 responses.
Tissue fibrosis is a pathologic process characterized by the abnormal accumulation of extracellular matrix in the intersti-
Generation of recombinant mouse ST2-Fc
The DNA sequence containing the extracellular region of murine ST2L was generated by RT-PCR from the total RNA of BALB-3T3 cells serum-starved for 36 h, followed by stimulation with 10 g/ml cyclohexamide and 10% serum for 20 h. The RT-PCR reaction was performed using primers 5Ј-TGCCATT-GCCATAGAGAGAC-3Ј (forward) and 5Ј-TAGTAGATGCTTCGGTGATC-3Ј (reverse) to amplify the region encoding amino acids 1-336 (GenBank Accession Number D13695). The obtained ST2L fragment was linked to a murine (m)IgG2a-Fc fragment and cloned into the CH269 transient expression vector. ST2-Fc protein was purified using protein A affinity purification.
Induction of hepatic fibrosis and mouse treatment
To induce chronic liver injury, mice were administered CCl 4 in mineral oil by gavage (1.75 ml/kg) in a total volume of 200 l weekly for 5 or 6 weeks. Control mice were treated with mineral oil only. In acute experiments, mice were killed on Days 1, 3, or 5 after a single dose of CCl 4 4 , and then twice per week for the duration of CCl 4 treatment. In acute experiments, mice were injected with ST2-Fc on Days -3 and 0. Hepatotoxicity was assessed by alanyltransferase (ALT) analysis in sera 24 h after the first dose of CCl 4 .
Immunohistochemistry (IH)
Three different liver lobes were taken from each mouse and incubated in 4% paraformaldehyde in PBS for 2 days prior to embedding for immunohistochemical analysis. General tissue damage was illustrated by H&E staining and apoptotic areas at early time-points by TUNEL staining.
TUNEL staining was performed using an ApopTag in situ apoptosis detection kit (Chemicon International, Temecula, CA, USA) according to the manufacturer's instructions. Labeled apoptotic cells were detected using 3Ј,3Ј-diaminobenzidine (DAB)/nickel chloride as the substrate. Slides were counterstained for 5 min with methyl green (Vector Laboratories, Burlingame, CA, USA). Hepatic collagen deposition was visualized using Sirius red staining of paraffin-embedded liver sections [32] .
Kupffer cells and infiltrating macrophages were detected by staining for F4/80, and F4/80-specific antibody (Clone CI:A3-1, Serotec Inc., Raleigh, NC, USA) was used at 20 g/ml. Tissue sections were pretreated with proteinase K (DakoCytomation, Denmark) for 5 min at room temperature. Binding of primary antibody was detected using a Vector Elite ABC kit (Vector Laboratories), using DAB substrate. Slides were counterstained with Mayer's hematoxylin for 1 min.
Transformed stellate cells were detected by staining for ␣-smooth muscle actin (␣SMA). Antibody specific for ␣SMA (Clone 1A4, DakoCytomation) was used at a 1:50 dilution with 30-min incubation. Heat-induced epitope retrieval pretreatment of tissue sections was performed in 10 mM citrate buffer, pH 6.0, for 30 s at 125°C, kept at 90°C for 10 s, and cooled to room temperature for an additional 20 min prior to immunostaining. Binding of primary antibodies to tissue elements was detected using an MM biotinylation kit (Biocare Medical, Concord, CA, USA) with DAB substrate. Slides were counterstained with Mayer's hematoxylin for 1 min.
Interstitial collagen quantification
A total of three sections from the liver (each from a different lobe) was stained for each mouse. Black and white pictures of Sirius red staining were made in polarized light at ϫ250 magnification. Tissue occupied the entire area captured by the camera so that total image area was identical in each picture (four to 10 pictures per liver). Vasculature normally containing collagen was removed electronically from each image, and the amount of interstistial collagen (white staining) was quantified using MetaMorph image analysis software (Universal Imaging Corp., Downingtown, PA, USA). Quantification is displayed in arbitrary units (one correlates to 1000 pixels).
Isolation and in vitro culture of intrahepatic lymphocytes
Livers were perfused through portal vein with PBS and excised, gall bladders removed, and the rest of the tissue homogenized in RPMI/5% FBS, centrifuged, resuspended in 0.02% collagenase IV, and incubated for 1 h at 37°C with constant shaking. Samples were diluted with cold RPMI, and hepatocytes were sedimented at 500 rpm for 2.5 min and discarded. Lymphocytes were purified using discontinuous Percoll gradient 45%/70%, washed in sterile media, and used for four-color flow cytometric analysis or for in vitro culture with or without anti-CD3ε mAb for 48 h. Supernatants were analyzed for cytokines by ELISA.
In vitro inhibition of TLR-4 signaling by ST2-Fc
RAW264.7/NF-B.luc Clone 31 was generated at Biogen Idec. Briefly, RAW 264.7 cells (ATCC TIB-71, American Type Culture Collection, Manassas, VA, USA) were cotransfected using Lipofectamine 2000 with the reporter NF-B luciferase (Clontech, Palo Alto, CA, USA) and a plasmid containing the neomycin-resistance gene (10:1), subjected to selection in 250 mg/ml Geneticin (G418), and cloned. For the assay, cells plated in a 96-well plate at 8 ϫ 10 4 cells/well overnight in triplicates were supplemented with media containing 10 ng/ml LPS alone, in combination with the ascending amounts of ST2-Fc or control IgG or with media alone. After incubation for 4 h at 37°C and removal of the media, cells were lysed, luciferase substrate was added, and the reading was performed on a luminometer Wallac 1450 MicroBeta Jet. A kinetic study showed that enhancement of the Th2 response by IHL isolated 1 day after CCl 4 gavage is observed following a single dose of ST2-Fc on Day -3 (relative to gavage; Fig. 1C ). However, delaying ST2-Fc treatment to Days -2 or -1 or to the day of CCl 4 gavage resulted in little if any effect. These data suggest that it takes several days for ST2-Fc to preset conditions needed for Th2 polarization of IHL, but once the milieu is created, polarization occurs within 24 h postinjury (Supplemental Fig. 1 ).
RESULTS

Recombinant
Recombinant ST2-Fc does not affect hepatic injury but accelerates the onset of fibrosis in CCl 4 -treated mice Analysis of ALT activity in sera 24 h post-CCl 4 -induced injury shows no shift in hepatotoxicity of ST2-Fc-treated mice ( Fig.  2A) . This observation is in good agreement with TUNEL and H&E staining, both of which fail to reveal a difference in the amount of apoptotic or otherwise damaged cells in liver at Day 1 (Fig. 2B , and data not shown). Immunohistochemical staining for F4/80 at Days 1-8 postinjury shows no significant difference in numbers or distribution of Kupffer cells (a potential (Fig. 2C) . Nevertheless, staining for ␣SMA shows more activated myofibroblasts (collagen-producing cells) in ST2-Fc-exposed, injured livers by Day 5 (Fig. 2D ). In accordance with that, Sirius red staining reveals a significant increase in the level of collagen deposition of ST2-Fc-treated livers 8 days after CCl 4 injury (Fig. 3) . Different types of tissue staining shown at specific time-points reveal the expected succession of events from initial injury to macrophage/Kupffer cell activation, which in turn induces transformation of slellate cells into myofibroblasts and result in collagen deposition. Together, with the in vitro data, this suggests that ST2-Fc treatment affects neither early CCl 4 -induced hepatic injury nor the magnitude of macrophage activation but rather enhances Th2 response to accelerate hepatic fibrosis.
Recombinant ST2-Fc maintains Th2 commitment and enhances collagen deposition in chronically injured liver
We next assessed whether the ST2-Fc-enhanced Th2 response can be maintained in chronically injured liver to accelerate fibrosis as measured by increased levels of collagen deposition. Mice gavaged weekly with CCl 4 for 5 weeks were dosed with ST2-Fc or control IgG twice a week for the duration of the experiment. At the termination of experiment, ex vivo-stimulated IHL from CCl 4 /ST2-Fc-treated but not from CCl 4 /IgGtreated mice demonstrated a selectively exaggerated Th2 response, including IL-4, IL-13, and to a lesser extent, IL-10. Th1 or inflammatory cytokines such as IFN-␥, IL-6, and RANTES were not affected by ST2-Fc (Fig. 4A) . All the changes were similar to that seen during the first week of treatment. Sirius red staining revealed a profound increase in the amount of fibrillar collagen depositions in the livers of the ST2-Fc-treated mice as compared with livers of the control group of mice (Fig. 4, B and C) .
CD4
ϩ cells are required for ST2-Fc-induced Type 2 response and fibrosis in CCl 4 -injured liver
Extensive four-color flow cytometry analyses of the IHL isolated from CCl 4 -injured livers were performed. Major T cell subsets (␣␤TCR
ϩ , and ␥␦TCR ϩ CD8␣ -) were analyzed for the expression of major T cell coreceptors (CD2, CD5, CD28, and CD90), activation markers (CD25, CD44, CD54, CD62L, CD69, and CD223), and integrins/differentiation markers (CD11a, CD18, CD29, CD49a, CD49b, CD49d, ␤7, CD103, CD16/32, CD122, and TIM-3). Additional analysis included IH B cells, macrophages/Kupffer cells, and granulocytes. Significant differences in IHL composition resulting from ST2-Fc treatment were not observed at early time-points or after 5 weeks of treatment.
To address the cellular source of Type 2 cytokines, we used a depleting anti-CD4 mAb to render WT BALB/c mice CD4 ϩ T cell-deficient. Administration of the anti-CD4 antibody at Days -5, -3, and 0, relative to CCl 4 gavage, eliminates 93-
97% of CD4
ϩ cells in spleen and liver (data not shown) and results in complete abrogation of IL-4, -5, -10, and -13 secretion by IHL from the CCl 4 /ST2-Fc-treated group (Fig. 5A) . Furthermore, staining hepatic tissue for collagen at Day 8 post-CCl 4 gavage shows that CD4 ϩ T cell depletion prevents the acceleration of fibrosis caused by ST2-Fc treatment (Fig. 5B) .
We wanted to discriminate between CD4 ϩ Th lymphocytes and CD4
ϩ NKT cells, which constitute up to 50% of the total IHL CD4 ϩ population. To address a possible role of invariant (i)NKT cells, we used CD1 KO mice, where iNKT cells do not develop. As shown in Figure 6 , the absence of iNKT cells does not result in a significant shift in Th2 cytokine production stimulated by ST2-Fc.
These results indicate that the CD4 ϩ T lymphocyte compartment of IHL is the major factor of accelerated fibrogenesis and an important source of Type 2 cytokines induced by ST2-Fc in injured liver and suggest that it is through their Th2 cytokine response that CD4 ϩ IH T lymphocytes enhance hepatic fibrosis.
Profibrotic activity of ST2-Fc is driven by Th2 cytokines
To evaluate whether enhanced Th2 cytokine production was indeed a trigger of fibrogenesis or rather a side-effect of ST2-Fc treatment, we extended our studies of CCl 4 g). The first dose of antibody was delivered 3 days before the first oil/CCl 4 dose. Twenty-four hours after the fifth weekly gavage with CCl 4 or oil, three mice from each group of eight were killed, IHL were isolated, and cytokine production by IHL was analyzed. Twenty-four hours after the fifth weekly gavage with CCl 4 or oil, five mice of each group were killed, and collagen-specific Sirius red staining of liver sections was performed to quantify interstitial collagen deposition. significantly in IL-4R␣ KO livers (Fig. 7) . Thus, the ability of ST2-Fc to trigger hepatic fibrosis in injured liver is in fact mediated by Th2 cytokines.
Cytokine response in CCl 4 -injured liver is TLR-4-mediated
As ST2 activity was attributed to its ability to modulate TLR-2, -4, and -9 signaling [22] , and TLR-4 engagement was shown to tolerize against subsequent CCl 4 -induced liver injury [33] , we wanted to see whether TLR-4 is an important factor in CCl 4 -triggered inflammation. To address this question, we assessed the effects of ST2-Fc administration to TLR-4-deficient, CCl 4 -gavaged BALB/c mice. In contrast to WT mice, in the absence of TLR-4, cytokine secretion by IHL from CCl 4 -treated and CCl 4 /ST2-Fc-treated groups was abrogated completely or reduced drastically (Fig. 8) . The fact that dramatic reduction occurs to all Th1, Th2, and inflammatory factors points to TLR-4 as an indispensable mediator of acute inflammation in CCl 4 -injured liver.
Although the mechanism, whereby ST2L can regulate TLRs and IL-1R, was ascribed to its ability to sequester adaptor protein MyD88 [22] , similar activity of soluble ST2 remains less characterized. To demonstrate that ST2-Fc can interfere directly with TLR-4 signaling and to address a mechanism of its action, we used a TLR-4 ϩ monocyte cell line RAW264.7 with a luciferase gene introduced under the control of the NF-B promoter. NF-B activation, induced in RAW cells by LPS, was assessed by luciferase activity. In our experiments, ST2-Fc demonstrated significant inhibition of TLR-4-mediated NF-B activation in a dose-dependent manner (Supplemental Fig. 2 ), suggesting that soluble ST2 is able to disrupt the proinflammatory cascade downstream from TLR-4.
DISCUSSION
In the present study, we investigated the effect of exogenous IL-1R-related protein ST2 on an intrahepatic Th2 response. The results presented in this paper show that ST2 selectively stimulated production of Type 2 cytokines IL-4, -5, -10, and -13 by intrahepatic CD4 ϩ T cells of chemically injured liver. Although ST2-Fc was injected i.p., it had no effect on splenic or mesenteric lymph nodes' lymphocytes and elicited Th2 response in the liver only as long as this tissue sustained massive injury 24 -72 h post-ST2-Fc injection. Th2 cytokines peaked 24 h after injury and then faded in spite of repeated injections of ST2-Fc. These data suggested that ST2-Fc induced mediator(s), which in the milieu created by massive hepatocyte death, drove rapid Th2 differentiation.
Continuous ST2-Fc treatment, accompanied by repeated CCl 4 -induced hepatic injury, leads to accelerated and enhanced liver fibrosis as compared with mice receiving CCl 4 and control IgG. Acceleration of hepatic fibrosis by ST2-Fc was The fact that an exaggerated Th2 response resulted in enhanced hepatic fibrosis is not particularly surprising. Fibrosis affects different tissues with a domination of Type 2 cytokine production, including IL-4, -5, -10, and -13 [30, 34 -38] . There are several pathways used by Type 2 cytokines to support fibrogenesis. IL-13 can induce tissue fibrosis via direct stimulation of collagen production by activated fibroblasts [35, 36] , as well as through activation of the major fibrogenic cytokine TGF-␤ [38] . Moreover, IL-4 and IL-13 were shown to trigger an arginase I-dependent synthetic pathway in alternatively activated macrophages and dendritic cells (DC) [39, 40] , leading to production of proline, an essential amino acid for collagen synthesis. IL-10 has also demonstrated a fibrogenic activity in lung, reportedly mediated by IL-4 and IL-13 [37] .
The ability of ST2-Fc to enhance a Th2 response reported in this paper is intriguing. ST2 interference with Th1/Th2 balance has been under investigation, as ST2 was found to be a selective marker of Th2 cells [5, 6] . Multiple in vivo studies addressing this issue produced seemingly contradictory data. Overproduction of TG sST2 or injection of recombinant ST2-Fc efficiently blocked allergen-induced Th2 response in pulmonary mucosa [5, 14, 18] or suppressed Th1 inflammation in arthritic joints [23] but failed to affect Th2 responses against L. major in footpads [25] or against N. brasiliensis in intestinal mucosa [24] and greatly enhanced the Th2 response in injured liver (this study). To reconcile these data, we suggest that there are two distinct modes of action of the ST2 pathway as related to regulation of inflammation and underlying Th1/Th2 balance.
In one mode, interaction between IL-33 or an unknown ligand expressed by DC and ST2L on Th2 cells delivers positive signaling into the latter, thus eliciting a Th2 response [13, 14] . Overproduced TG sST2 or exogenous ST2-Fc as well as anti-ST2 mAb or ST2 deficiency in KO mice disrupt this circuit and block the Type 2 response in pulmonary mucosa [5, 14, 16, 18 -20] , suggesting that the ST2 pathway is indispensable for triggering/maintenance of Th2 reactions in this tissue. This is probably why other important Th2-supporting pathways such as B7RP-1/ICOS appear redundant in the lung [41] . Conversely, the lack of effect of ST2 on intestinal Th2 response induced by N. brasiliensis could be ascribed to this organism's ability to secrete its own factors driving Th2 differentiation [42] , similar to other helminthic parasites Schistosoma mansoni [43] and Acanthocheilonema viteae [44] . It is tempting to speculate that L. major also produces a factor triggering the Th2 response in BALB/c mice, thus making the ST2 pathway redundant in parasite-infested tissue.
In a different mode, sST2 or ST2L disrupts TLR-mediated signaling and thus blocks the Th1 response supported by the TLR pathway. In accordance with this paradigm, endogenous sST2 was demonstrated to be an important mediator in a negative-feedback loop controlling a TLR-4-driven, inflammatory response through an unknown, ST2-binding receptor expressed by macrophages [21] . Similarly, up-regulation of ST2 occurred upon TLR-2/TLR-1 or TLR-2/TLR-6 engagement and was accompanied by a decrease in Th1 cytokines IL-12 and IL-18 [45] . Regulatory activity of ST2 was expanded to TLR-2 and -9 and IL-1R and was ascribed to the ability of ST2L to sequester adaptor protein MyD88 shared by TLR-2, -4, and -9 and IL-1R [22] . Consistent with the known propensity of endogenous sST2 to modulate acute tissue inflammation [3] , exogenous ST2-Fc, similar to sST2, was shown to suppress Th1-driven murine collagen-induced arthritis [23] , endotoxic shock [21, 22] , and polymicrobial peritonitis [45] .
We find our data consistent with the TLR-blocking effect of ST2-Fc, which could result in subdued Th1 and enhanced Th2 responses. CCl 4 -induced hepatic injury appears to be at least in part mediated by TLR signaling [33] , and in our experiments, CCl 4 -induced cytokine production by IHL was abrogated completely in TLR-4-deficient BALB/c mice. Moreover, a prior engagement of TLR-4 or IL-1R, known to induce sST2 as a negative regulatory factor [21, 22] , attenuates hepatic injury by CCl 4 [33] . It is important that in mice deficient in TLR signaling, Th1-immune response is compromised [46] and in some cases, defaults to a Th2 response [47] . In the latest support of this concept, S. mansoni infection of livers of MyD88 KO mice (with disrupted TLR signaling) leads to increased Th2 response as manifested by IL-13 production and results in enhanced hepatic fibrosis [48] . It is thus tempting to speculate that in our study, recombinant ST2-Fc also modifies CCl 4 -induced TLR signaling and lets a fibrogenic Th2 response prevail. The exact mechanism of involvement of the ST2 pathway in hepatic injury will require further studies for its clarification. In summary, we have demonstrated for the first time that exogenous ST2 elicits a strong Th2 response in chemically injured liver.
